AMY GUTSHALL: Open Payments
NPI 1750934816 · MORGANTOWN, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,166 in 72 payments from 16 companies in 2025. Trend: 2023 $832 · 2024 $820 · 2025 $1,166
Food & beverage: $1,166
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $389 |
| Alkermes, Inc. | 10 | $187 |
| Teva Pharmaceuticals USA, Inc. | 5 | $96 |
| Vanda Pharmaceuticals Inc. | 4 | $85 |
| Lundbeck LLC | 2 | $64 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| Neurocrine BioSciences, Inc. | 2 | $34 |
Products named: VRAYLAR, ARISTADA, REXULTI, FANAPT, AUSTEDO XR, COBENFY, Sunosi, SPRAVATO.
Industry payments across WV — which companies pay providers there.
